INTRODUCTION
Calmodulin is a small, highly conserved Ca# + -binding protein which acts as a Ca# + -dependent regulator of many proteins, including enzymes, ion channels and cytoskeletal elements [2] . It is present in micromolar concentrations in all eukaryotic cells [3] and is especially abundant in brain [4] . Calmodulin is not only involved in decoding Ca# + signals, but also in regulating, both directly or via protein kinases and phosphatases, the many Ca# + -transporting proteins that control the cytosolic Ca# + concentration. The latter targets include cyclic-nucleotide-gated [5] and voltage-gated [6, 7] Ca# + channels, plasma-membrane Ca# + pumps [8] , the Drosophila Ca# + channels encoded by the trp and trpl genes [9] [10] [11] and N-methyl--aspartate receptors [12] .
Intracellular Ca# + channels are also regulated by calmodulin. Both ryanodine and InsP $ receptors are phosphorylated by Ca# + -calmodulin-dependent protein kinase II and de-phosphorylated by calcineurin [13] [14] [15] [16] [17] [18] . In addition, calmodulin, in both the absence and presence of Ca# + , binds directly to both ryanodine [19, 20] and InsP $ receptors [21] [22] [23] [24] . Ca# + -calmodulin binds to a short stretch of residues within the modulatory domain of the type-1 InsP $ receptor [22] and a similar sequence is present in type-2, but not type-3, InsP $ receptors. The functional consequences of calmodulin binding to this site are unknown. A Abbreviations used : CLM, cytosol-like medium ; cyt1-18, fusion proteins derived from type-1 InsP 3 receptor as defined in [1] ; HSAB, Nhydroxysuccinimidyl-4-azidobenzoate ; Sf9/InsP 3 R1, Spodoptera frugiperda cells expressing rat type-1 InsP 3 receptor ; SPA, scintillation proximity assay ; GST, glutathione S-transferase ; BAPTA, bis-(o-aminophenoxy)ethane-N,N,Nh,Nh-tetra-acetic acid. 1 To whom correspondence should be addressed (e-mail cwt1000!cam.ac.uk).
tillation proximity assay to measure "#&I-calmodulin binding to glutathione S-transferase-fusion proteins, we identified two regions of the type-1 InsP $ receptor (cyt1, residues k6 to 159 ; and cyt11, residues 1499-1649) that bound "#&I-calmodulin. The higher-affinity site (cyt11) was also photoaffinity labelled with Nhydroxysuccinimidyl-4-azidobenzoate (HSAB)-calmodulin. We speculate that Ca# + -independent binding of calmodulin to a site within the first 159 residues of the type-1 InsP $ receptor inhibits InsP $ binding and may thereby regulate the kinetics of Ca# + release. Ca# + -dependent inhibition of Ca# + release by calmodulin is mediated by a different site : it may reside on an accessory protein that associates with all three receptor subtypes, or Ca# + -calmodulin binding to a site lying between residues 1499 and 1649 of the type-1 receptor may inhibit Ca# + release from any tetrameric receptor that includes a type-1 subunit.
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second site, which is present in type-1, but appears not to be present in type-3, InsP $ receptors, binds calmodulin with similar affinity in both the absence and presence of Ca# + ; occupancy of this site inhibits InsP $ binding [23, 24] . This calmodulin-binding site may be located within the N-terminal region of the type-1 receptor, because calmodulin, in both the presence and absence of Ca# + , inhibits InsP $ binding to a protein that includes only the first 581 residues of the receptor [25] . Again, however, the functional consequences of calmodulin binding to this Ca# + -independent site have not been established. We have speculated that it may inhibit InsP $ -evoked Ca# + mobilization and thereby allow changes in free calmodulin concentration to modulate InsP $ -receptor sensitivity [23] . In the present study, we directly test this speculation by examining whether the effects of calmodulin on inhibition of InsP $ binding (Ca# + -independent and specific for type-1 receptors) match the effects of calmodulin on InsP $ -evoked Ca# + mobilization.
METHODS AND MATERIALS
Cell culture and isolation of hepatocytes SH-SY5Y human neuroblastoma cells (American Type Culture Collection, Bethesda, MD, U.S.A. ; passages [28] [29] [30] [31] [32] [33] [34] [35] were grown at 37 mC in Dulbecco's modified Eagle's medium supplemented with 10 % foetal calf serum, 7 mM -glutamine and 0.9 % nonessential amino acids in an atmosphere of 5 % CO # and 95 % air. Cells were passaged every 7 days when they were confluent. The same methods were used to culture RINm5F insulinoma cells (from Dr. P. Brown, Manchester University, Manchester, U.K. ; passages 78-83), except for changing the medium to RPMI 1640 and reducing the concentration of foetal calf serum to 5 %. Rat hepatocytes were isolated by collagenase digestion and stored for up to 24 h at 4 mC in Eagle's minimal essential medium buffered with 26 mM NaHCO $ [26] .
45 Ca 2 + -flux measurements SH-SY5Y and RINm5F cells were harvested by scraping into ice-cold medium containing 155 mM NaCl, 10 mM Hepes (pH 7.4) and 0.5 mM EGTA, and pelleted by centrifugation (650 g for 2 min). Cells were resuspended in Ca# + -free medium (100 mM KCl, 20 mM NaCl, 5 mM MgCl # , 1 mM EGTA, 20 mM Hepes, pH 7, at 37 mC) and permeabilized by incubation with saponin at 37 mC (10 µg\ml, 5 min). Permeabilized cells were centrifuged (650 g, 2 min) and resuspended in a cytosol-like medium (CLM ; 100 mM KCl, 20 mM NaCl, 5 mM MgCl # , 20 mM Hepes, 240 µM EGTA, 64 µM CaCl # , pH 7, at 20 mC) supplemented with ATP (1.5 mM), phosphocreatine (5 mM), creatine phosphokinase (1 unit\ml), carbonyl cyanide p-trifluormethoxyphenylhydrazone (FCCP ; 10 µM) and %&CaCl # (8 µCi\ml). The free [Ca# + ] of CLM, measured using fura 2, was 200 nM. The intracellular stores were allowed to actively accumulate %&Ca#+ for 15 min at 20 mC before addition of InsP $ for a further 2 min. The %&Ca#+ contents of the stores were determined by rapidly terminating the incubations with ice-cold sucrose (310 mM, pH 7) containing trisodium citrate (10 mM) followed by filtration through Whatman GF\C filters [27] .
The effects of calmodulin on InsP $ -evoked Ca# + release were first examined by including calmodulin throughout both the loading period and subsequent exposure to InsP $ (see Figure 1 and Table 1 , below). In subsequent experiments examining the Ca# + -dependence of the effects of calmodulin (see Table 2 , below), permeabilized cells loaded to steady state with %&Ca#+ were diluted into CLM with or without calmodulin (10 µM) and with the free [Ca# + ] buffered by bis-(o-aminophenoxy)ethane-N,N,Nh,Nh-tetra-acetic acid (BAPTA ; 5 mM) at either 200 nM or $ 4 nM (nominally Ca# + -free) ; thapsigargin (1 µM) was also included to prevent further Ca# + uptake. After 5 min, InsP $ was added, and 2 min later the %&Ca#+ contents of the stores were determined.
Permeabilized hepatocytes were actively loaded with %&Ca#+ (5 min at 37 mC) in medium (140 mM KCl, 20 mM NaCl, 2 mM MgCl # , 1 mM EGTA, 20 mM Pipes, pH 7, 300 µM CaCl # ; free [Ca# + ] l 200 nM) as described previously [27] . Where indicated, calmodulin was included during this incubation and the effects of InsP $ were examined by adding it for 1 min before terminating the reactions as described above. The different temperatures for experiments with hepatocytes and cultured cells were required to optimize active Ca# + uptake for each cell type. %&Ca#+ release from cerebellar microsomes was determined as described previously [23] . In all experiments, active %&Ca#+ uptake is defined as that which was released by 10 µM ionomycin.
Measurements of calmodulin binding
Scintillation proximity assays (SPAs) and photoaffinity labelling were used to identify calmodulin-binding sites within the type-1 InsP $ receptor.
For SPAs, Protein A-coated SPA beads (3 mg\ml ; Amersham, Little Chalfont, Bucks, U.K.) were incubated (1 h, 2 mC) in binding medium (5 mM KH # PO % , 20 mM Hepes, 10 mg\ml BSA, 0.1 % Surfact-Amps X-100, pH 7.2) with a rabbit antiglutathione S-transferase (GST) antibody (0.12 mg\ml ; Molecular Probes, Leiden, The Netherlands). After centrifugation (6000 g, 2 min at 2 mC), GST-fusion proteins (24 µg\ml) were coupled to the beads during a further incubation (2 h at 2 mC) in binding medium. The beads, now with GST-fusion protein attached to them via the antibody, were washed (6000 g, 2 min at 2 mC) and resuspended (1.5 mg\ml) in binding medium supplemented with 100 µM BAPTA, 0.4 nM"#&I-calmodulin and appropriate concentrations of unlabelled calmodulin ; Ca# + -containing medium also contained 300 µM CaCl # . After 15 min at 2 mC, equilibrium binding of "#&I-calmodulin was determined by counting vials at 2 mC in a Packard TriCarb 2200CA scintillation counter. The amount of each GST-fusion protein coupled to the SPA beads was quantified by boiling a sample of the beads in SDS sample buffer before SDS\PAGE and quantitative Westernblot analysis using a monoclonal anti-GST antibody (Sigma, Poole, Dorset).
For photoaffinity labelling, N-hydroxysuccinimidyl-4-azidobenzoate (HSAB)-calmodulin was prepared as described in [28] . Briefly, HSAB (20 µl, 10 mM in DMSO) was incubated with calmodulin (80 µl of 3.75 µM in 200 mM sodium borate, pH 8.5) in darkness for 1 h at room temperature. Excess HSAB was quenched by addition of 50 mM Tris\HCl (500 µl, pH 7.4) and separated from HSAB-calmodulin on a G-25 Sephadex column (Pharmacia, St Albans, Herts, U.K.). GST-fusion proteins (0.8 µg) were incubated (10 min on ice) with HSAB-calmodulin (235 nM) in 75 µl of 50 mM Tris (pH 7.4) containing 0.1 % Surfact-Amps X-100 and either 700 µM CaCl # or 7 mM EGTA. The incubations were then irradiated (254 nm, 20 min ; Mineralight UVGL-58), and EGTA was added (final concentration, 6.25 mM) to the samples that contained Ca# + (to ensure that calmodulin migrated uniformly in SDS\PAGE). Western blotting was performed using a monoclonal antibody to calmodulin (Upstate Biotechnology, Lake Placid, NY, U.S.A.) and a goat anti-mouse secondary antibody (Sigma) ; immunoreactive bands were detected using the Pierce Supersignal Ultra system and Hyperfilm (Amersham). The same methods applied to purified calcineurin (Upstate Biotechnology) successfully labelled $ 20 % of the 60-kDa subunit of the enzyme only when Ca# + was present and only after irradiation (results not shown).
GST-fusion proteins derived from the mouse type-1 InsP $ receptor were expressed in Escherichia coli as described previously [1] ; the same nomenclature is used here to describe the fusion proteins (see Figure 3a , below). Mutagenesis of the cyt11 protein (cyt proteins are fusion proteins derived from type-1 InsP $ receptor, as defined in [1] ) was performed using the Quick Change system according to the manufacturer's instructions (Strategene). The primers used were 5h-GATAACCGCGCGT-TCAGGG-3h and 5h-CCCTGAACGCGCGGTTATC-3h, and the mutation was confirmed by automated sequencing. Methods for the expression of type-1 InsP $ receptors in Sf9 cells were described previously [29] .
Phosphorylation of cerebellar InsP 3 receptors
InsP $ receptors were purified from rat cerebella as described previously [30] except that a protease-inhibitor cocktail [29] was present throughout. The purified protein bound InsP $ with high affinity (K d l 6.6p0.3 nM, n l 3) and, after SDS\PAGE, silverstaining identified a single band ($ 260 kDa). For phosphorylation reactions, purified receptor (2.1 µg) was incubated at U.K.). ATP, creatine phosphate and creatine phosphokinase were from Boehringer (Lewes, East Sussex, U.K.). Calmodulin was purified from pig brain as described previously [31] and recombinant chicken calmodulin was from Alexis (Nottingham, U.K.) : calmodulin from the two sources gave indistinguishable results and was used interchangeably. HSAB and Surfact-Amps X-100 were from Pierce and Warriner (Chester, U.K.). Cellculture media were from Gibco-BRL (Paisley, Scotland, U.K.). All other reagents, including foetal calf serum, were from Sigma. Figure 1a) . Calmodulin (10 µM), present during both the loading period and the subsequent incubation with InsP $ , significantly reduced the sensitivity of the intracellular stores to InsP $ in each cell type. In each case, the EC &! for InsP $ -evoked Ca# + mobilization increased by $ 2-fold, without affecting the response to a maximal concentration of InsP $ ( Table 1 ). The 2-fold decrease in sensitivity is, however, less than the 6-fold decrease observed in cerebellar microsomes (Table 1) [23] and the $ 10-fold shift in A7r5 cells [35] . The apparent decrease in the maximal response to InsP $ in RINm5F cells resulted from calmodulin stimulating Ca# + accumulation into an InsP $ -insensitive pool : the total amount of %&Ca#+ released by 10 µM InsP $ was unaffected by calmodulin ; it was 101p16 % (n l 3) of that in its absence. Calmodulin also inhibited InsP $ -evoked Ca# + release when the effects of InsP $ were examined in the presence of thapsigargin (1 µM), indicating that the reduced response was not the result of calmodulin stimulating re-uptake of Ca# + (Figure 1a , inset).
RESULTS

Inhibition of InsP
Characteristics of calmodulin inhibition of InsP 3 -evoked Ca 2 + release in SH-SY5Y cells
Previous work established that InsP $ binding to full-length recombinant type-1, but not type-3, InsP $ receptors was inhibited by calmodulin in a Ca# + -independent fashion [23, 24] . Our subsequent work therefore focused on SH-SY5Y cells because they express predominantly type-1 InsP $ receptors [32] . Figure 2 (a) demonstrates that in normal CLM (free [Ca# + ], 200 nM), halfmaximal inhibition of the response to a submaximal concentration of InsP $ (200 nM) occurred with a calmodulin concentration of $ 15 µM. Calmodulin ( 100 µM) affected neither Ca# + uptake by SH-SY5Y cells nor their responses to a maximal concentration of InsP $ (results not shown). Calmidazolium (50 µM) almost abolished active %&Ca#+ uptake and a peptide antagonist (20 µM) derived from Ca# + -calmodulindependent protein kinase II (Pep-3 in [24] ) substantially reduced it ; calmodulin antagonists could not therefore be used during the loading period to establish the specificity of the calmodulin effect. When either antagonist was added with calmodulin (10 µM) and thapsigargin (1 µM) to cells that had already been loaded with %&Ca#+, both antagonists decreased the Ca# + content of the stores (suggesting that endogenous calmodulin may regulate the Ca# + leak), but more importantly the ability of calmodulin to inhibit the Ca# + release evoked by a submaximal concentration of InsP $ (200 nM) was abolished by the antagonists (Figure 2b ). Further evidence that the effect of calmodulin is specific is provided by the indistinguishable inhibition of InsP $ -evoked Ca# + release observed with recombinant chicken calmodulin and calmodulin purified from pig brain, suggesting that the inhibition is unlikely to result from contamination of the calmodulin preparations.
Cyclosporin A (1 µM), an inhibitor of calcineurin [36] , had no effect on the inhibition of InsP $ -evoked Ca# + release caused by 10 µM calmodulin, and whereas another calcineurin inhibitor, FK-506 (300 nM), itself inhibited InsP $ -evoked Ca# + release, it Ca 2 + -calmodulin inhibition of InsP 3 receptors too failed to prevent further inhibition by calmodulin ( Figure  2c ). The effect of calmodulin did not result from enhanced metabolism of InsP $ , because calmodulin (10 µM) also reduced the sensitivity of SH-SY5Y cells to adenophostin A, an agonist of InsP $ receptors that cannot be metabolized [37] (Figure 1b) . Indeed, the decrease in sensitivity caused by calmodulin was slightly greater for adenophostin A (3.6-fold ; EC &! increased from 4.7p3 to 17p2 nM) than for InsP $ (2.1-fold ; EC &! increased from 90p6 to 191p6 nM).
The effect of calmodulin was relatively slow in onset. When present during the loading of cerebellar microsomes with %&Ca#+, calmodulin (10 µM) inhibited the response to a submaximal concentration of InsP $ (60 nM) by 91p11 % when included for 5 min, but by only 25p5 % when included for 1 min (results not shown). In the unidirectional %&Ca#+-efflux experiments required to assess the Ca# + -dependence of the calmodulin effect (see the Methods and materials section), it is therefore difficult to both retain sufficient Ca# + within the stores and allow sufficient time for the maximal effect of calmodulin. Nevertheless, Table 2 demonstrates that under these conditions in SH-SY5Y cells, calmodulin inhibited responses to InsP $ , but only in the presence of Ca# + .
Binding of calmodulin to type-1 InsP 3 receptors
Our previous work [24] established that "#&I-calmodulin bound to two distinct low-affinity sites on membranes prepared from Sf9 cells expressing type-1 InsP $ receptors : a Ca# + -dependent site and a Ca# + -independent site. Attempts to identify these sites by photoaffinity-labelling membranes of Spodoptera frugiperda cells expressing rat type-1 InsP $ receptor (Sf9\InsP $ R1) with HSABcalmodulin (10 µM) were unsuccessful because there was too much non-specific binding (results not shown). However, using a SPA to measure specific "#&I-calmodulin binding to GST-fusion proteins (cyt1-18) representing the full length of the type-1 InsP $ receptor [1] , we identified specific "#&I-calmodulin binding to two fusion proteins (Figure 3a) . Both cyt1 (residues k6 to 159) and cyt11 (residues 1499-1649) bound "#&I-calmodulin in the absence of Ca# + , and for both fusion proteins the specific binding was increased in the presence of 200 µM free [Ca# + ]. From equilibrium-competition binding studies (Figure 3b) , the affinities of the calmodulin-binding sites in cyt1 were significantly lower (K d $ 1 µM) than those in the cyt11 fragment (K d $ 100 nM ; Table  3 ) ; the former more closely approximate the affinities of the calmodulin-binding sites previously detected by "#&I-calmodulin binding to Sf9\InsP $ R1 membranes (K d $ 1 µM) [24] . Photoaffinity labelling of the same GST-fusion proteins clearly identified HSAB-calmodulin binding to cyt11 in both the absence and presence of Ca# + , but failed to detect binding to the loweraffinity sites in cyt1 (Figure 3c ). Cyt11 includes the sequence (1564-1585) to which Yamada et al. [22] attributed all Ca# + -calmodulin binding in the type-1 InsP $ receptor, and mutation of Trp"&(' to Ala within this sequence abolished Ca# + -calmodulin binding [22] . We have also confirmed that a peptide corresponding to residues 1564-1585 of the type-1 receptor binds Ca# + -calmodulin, but loses that ability after mutation of Trp"&(' [24] . However, while the analagous mutation (Trp"&(' to Ala) in cyt11 reduced specific "#&I-calmodulin binding by 63p9 % in the presence of Ca# + , it had a similar effect in the absence of Ca# + (a reduction of 67p18 %).
Calmodulin and phosphorylation of type-1 InsP 3 receptors by protein kinase A
The Ca# + -calmodulin-binding site within the type-1 InsP $ receptor [22] is only a few residues away from a residue (Ser"&))) that is phosphorylated by protein kinase A. We therefore examined whether calmodulin affected phosphorylation of type-1 InsP $ receptors. In our experiments, half-maximal phosphorylation of purified cerebellar InsP $ receptors by protein kinase A occurred after 30 min (Figure 4 ). Calmodulin (10 µM) in the presence of a free [Ca# + ] of 500 µM (to ensure saturation of the calmodulin with Ca# + ) had no effect on the protein kinase A-catalysed phosphorylation.
DISCUSSION
Ca# + -independent binding of calmodulin to both purified and native cerebellar InsP $ receptors (type 1) and to full-length recombinant type-1, but not type-3, InsP $ receptors was shown previously to inhibit InsP $ binding [23, 24] . Because calmodulin also inhibits InsP $ -evoked Ca# + mobilization from cerebellar microsomes [23] A single Ca# + -independent calmodulin-binding site [24] located within the first 581 residues of the type-1 InsP $ receptor appears to mediate the effects of calmodulin on InsP $ binding [25] . The present work suggests that this site probably lies within the first 159 residues (i.e. cyt1 ; Figure 3a) , which is just outside the InsP $ -binding core (residues 226-576) [38, 39] and is therefore consistent with previous work demonstrating that Ca# + -independent calmodulin binding is not prevented by InsP $ [23] . We speculated previously [23] that Ca# + -independent calmodulin binding might inhibit InsP $ -evoked Ca# + mobilization, but both the present work (Table 2 ) and earlier work with A7r5 cells [35] found no effect of calmodulin on the extent of the Ca# + mobilization evoked by InsP $ in the absence of cytosolic Ca# + . While our work was under review, Michikawa et al. [40] also reported that cerebellar InsP $ receptors were inhibited by calmodulin only in the presence of Ca# + . An alternative possibility is suggested by the observation that InsP $ binding to its receptor is followed rapidly by a change in the receptor to a state that binds InsP $ with increased affinity but which is less capable of mediating Ca# + release ; a partially inactivated, high-affinity state [41] . Ca# + -independent calmodulin binding might therefore decrease InsP $ binding by favouring the low-affinity acti e conformation and would thereby increase the initial rate of Ca# + release, possibly without appreciably affecting its final extent. High-resolution measurements of the kinetics of InsP $ -evoked Ca# + release will be required to test this speculation directly.
We can be less certain of the site through which Ca# + -calmodulin inhibits InsP $ -receptor function ( Figure 1 ) : it may reside within the receptor itself or on an accessory protein. ATP is not required for calmodulin inhibition of InsP $ -evoked Ca# + release [35] , calcineurin is not involved (Figure 2b) , and nor does calmodulin influence phosphorylation of the type-1 receptor by protein kinase A (Figure 4) . It seems unlikely, therefore, that calmodulin mediates its effects via either phosphorylation or dephosphorylation of the InsP $ receptor. An attractive possibility is that the Ca# + -dependent calmodulin-binding site within cyt11 (Figure 3) mediates the functional effects of calmodulin, but this explanation is not easily reconciled with all the experimental evidence. First, the short sequence (Lys"&'%-His"&)&) within cyt11 to which Yamada et al. [22] first mapped the Ca# + -calmodulin binding site is present in receptor types 1 and 2, but absent from type-3 receptors, yet calmodulin inhibits InsP $ -evoked Ca# + release from cells expressing predominantly type-1, -2 or -3 InsP $ receptors (Table 1) . Whereas the peptide corresponding to the site identified by Yamada et al. plainly binds Ca# + -calmodulin [22, 24] , our results suggest that these residues may not provide the entire site to which Ca# + -calmodulin binds in type-1 receptors, because the mutation (Trp"&(' to Ala) which abolished calmodulin binding to the peptide [22] only partially reduced "#&I-calmodulin binding to cyt11. It seems possible that the methods used in the original study (adherence to a calmodulin-Sepharose column) may have detected only high-affinity calmodulin-binding sites and may therefore have attributed a substantial decrease in calmodulin binding (as occurred in our mutant cyt11 protein) to a complete loss of the site. In summary, it remains possible that the determinants of Ca# + -calmodulin binding, while including the region identified by Yamada et al. [22] , may also involve additional residues within cyt11 that may be expressed in other subtypes. Even that explanation, however, is difficult to reconcile with our inability to detect specific "#&I-calmodulin binding to recombinant full-length type-3 InsP $ receptors in either the presence or absence of Ca# + [24] . An alternative possibility is that because the cells we used express only $ 80 % of the predominant receptor subtype (the remainder being largely type 1), each tetrameric receptor could conceivably include a type-1 subunit and if its binding of Ca# + -calmodulin were to cause inhibition of the entire channel complex then the functional effects of Ca# + -calmodulin might be mediated entirely via binding to a site within cyt11, but present only in type-1 (and possibly type-2) InsP $ receptors. We suggest that Ca# + -independent binding of calmodulin to a site within the first 159 residues of the type-1 InsP $ receptor inhibits InsP $ binding and may thereby regulate the kinetics of Ca# + release ; it is not, however, the means whereby calmodulin inhibits InsP $ -evoked Ca# + release. Only Ca# + -calmodulin [35, 40] (Table 2) has so far been shown to inhibit InsP $ -evoked Ca# + release. The site to which Ca# + -calmodulin binds to cause inhibition may reside on an accessory protein that associates with all three receptor subtypes, or Ca# + -calmodulin binding to a site between residues 1499 and 1649 of the type-1 receptor may inhibit Ca# + release from any tetrameric receptor that includes a type-1 subunit.
